Similar to exenatide, liraglutide and semaglutide conferred protective effects in rodent PD models with 6-hydroxydopamine (6OHDA), 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and human A53T α-synuclein transgenic mice (Zhang et al. 2019). The gene discussed is SNCA; the disease is Parkinson disease.